Phosphonic Acid Coupling Agent Modification of HAP Nanoparticles: Interfacial Effects in PLLA/HAP Bone Scaffold

Abstract

In order to improve the interfacial bonding between hydroxyapatite (HAP) and poly-l-lactic acid (PLLA), 2-Carboxyethylphosphonic acid (CEPA), a phosphonic acid coupling agent, was introduced to modify HAP nanoparticles. After this. the PLLA scaffold containing CEPA-modified HAP (C-HAP) was fabricated by selective laser sintering (frittage). The specific mechanism of interfacial bonding was that the PO32− of CEPA formed an electrovalent bond with the Ca2+ of HAP on one hand, and on the other hand, the –COOH of CEPA formed an ester bond with the –OH of PLLA via an esterification reaction. The results showed that C-HAP was homogeneously dispersed in the PLLA matrix and that it exhibited interconnected morphology pulled out from the PLLA matrix due to the enhanced interfacial bonding. As a result, the tensile strength and modulus of the scaffold with 20% C-HAP increased by 1.40 and 2.79 times compared to that of the scaffold with HAP, respectively. In addition, the scaffold could attract Ca2+ in simulated body fluid (SBF) solution by the phosphonic acid group to induce apatite layer formation and also release Ca2+ and PO43− by degradation to facilitate cell attachment, growth and proliferation.

3D Hierarchical, Nanostructured Chitosan/PLA/HA Scaffolds Doped with TiO2/Au/Pt NPs with Tunable Properties for Guided Bone Tissue Engineering

“…Moreover, the scaffolds' architecture seems to provide good conditions for cells' growth and do not hamper their natural behaviors [38]. The findings show that all of the prepared scaffolds can be considered to be non-toxic and can be used for further studies, which should be focused on in vivo experiments [42][43][44][45][46].…”

“…Their incorporation should provide extraordinary properties to the hierarchized scaffolds and promote biomineralization process [27,[32][33][34][35]. The proposed structure should enable cell adhesion and proliferation, along with osteogenic differentiation, since they meet architectural requirements for bone-tissue regeneration [40,[42][43][44][45][46].…”

Linc02349 promotes osteogenesis of human umbilical cord‐derived stem cells by acting as a competing endogenous RNA for miR‐25‐3p and miR‐33b‐5p

“…Recent advances have demonstrated that inducing the bone formation to restore the normal bone homeostasis is efficient for osteoporosis treatment 1 . Although osteogenesis induced by biological materials has gained much attention, classic methods are still applied in the studies of osteogenic differentiation of MSCs 2‐5 . Human umbilical cord‐derived mesenchymal stem cells (hUC‐MSCs), a stem cell population, possess many advantages relative to other cell sources, 6 including easily isolated, abundantly supply, 7 low immune rejection, 8 self‐renewing ability and multipotency 9 .…”

In situ decomposition of Ti2AlN promoted interfacial bonding in ZnAl-Ti2AlN biocomposites for bone repair

“…Girish et al [19,20] have studied the graphite particles reinforced Zn matrix composites and found that the hardness and strength were enhanced. However, they found it was difficult to form good interfacial bonding in metal matrix composite due to the large physical and chemical differences between the matrix and the reinforcing phase [21][22][23][24]. This will reduce the load transfer capacity of the enhancement phase [25][26][27][28].…”